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Background and Objectives: Although low-level laser therapy (LLLT) has been
demonstrated to have a biomodulatory eﬀect on periodontal tissue, no system-
atic review has exclusively addressed its eﬀectiveness as an adjunct to non-surgi-
cal periodontal treatment. This study aimed to evaluate whether an additional
beneﬁt exists for the application of LLLT compared with scaling and root plan-
ing (SRP) alone.
Material and Methods: An extensive search was conducted in the Cochrane
Library (Issue 8, 2015), PubMed (1997) and EMBASE (1947) before August
2015 for randomized controlled trials (RCTs). The bias risk was assessed with
the Cochrane tool for risk of bias evaluation. A meta-analysis was performed
using REVMAN 5.3.
Results: After independent screening of 354 initial records, eight publications
(seven RCTs) were included. However, six were rated as ‘having a high risk of
bias’ as a result of major methodological weakness in ‘allocation concealment’
and ‘blinding of key personnel’. Meta-analysis showed that LLLT-mediated
SRP demonstrated signiﬁcant short-term beneﬁts over SRP monotherapy in the
improvement of the probing pocket depth (p = 0.0009 at 1 mo; p = 0.03 at
2 mo) and the level of interleukin-1b in the gingival crevicular ﬂuid (p = 0.01 at
1 mo). Nevertheless, LLLT failed to show signiﬁcant additional intermediate-
term (3 and 6 mo) eﬀects in terms of clinical parameters and alveolar bone den-
sity.
Conclusion: These ﬁndings indicated that LLLT showed only short-term addi-
tional beneﬁts after conventional SRP. Its long-term eﬀects remain unclear due
to substantial methodological weaknesses and an insuﬃcient number of current
studies. Future RCTs with better designs and longer follow-up periods are
required to assess the eﬀectiveness of LLLT as an adjunctive treatment strategy
in patients with periodontal disease.
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For decades, periodontal disease has
been a major challenge for oral health
and quality of life (1). Chronic peri-
odontitis is an inﬂammatory disease
caused by infection with periodonto-
pathic bacteria that results in the
progressive destruction of the tooth-
supporting tissues and eventually
tooth loss (2). It is recognized that
non-surgical periodontal treatment by
subgingival scaling and root planing
(SRP) remains the most eﬀective
approach to eliminating the source of
infection (3). However, as an invasive
approach, conventional mechanical
SRP creates a wound in the already
inﬂamed periodontal tissue, and the
restoration of this tissue depends
largely on favourable cellular and
molecular responses (4,5).
To strengthen the eﬀects of non-
surgical periodontal treatment, high-
intensity laser irradiation using an
Er:YAG laser, Nd:YAG laser or
diode laser has been introduced for its
potential beneﬁts in the ablation of
calculi and debridement of pockets
and for its bactericidal eﬀects (6–8).
Nevertheless, its additional advan-
tages have been challenged by the
ﬁndings of several evidence-based
studies (9,10). In contrast to the
thermal eﬀects of high-power lasers,
low-level laser therapy (LLLT) is rec-
ommended for its photochemical role
in anti-inﬂammation, biostimulation
and analgesia within the domains of
low-power output (within the mW
range), low-energy dosage (102–
102 J/cm2) and appropriate wave-
lengths (600–1000 nm) (11–14).
Whereas thermal lasers may cause
damage to the root surface during
cutting and ablation (15), almost no
adverse events have been reported
with the use of the low-energy laser,
also known as the soft or therapeutic
laser, which is targeted mainly at soft
tissue, and does not cause perceptible
temperature changes (12–14). The
most commonly used types of low-
level laser include the He-Ne laser
and the increasingly popular diode
lasers (GaAlAs laser, InGaAlP laser,
etc.) (12). Since its introduction in
1960s, LLLT has been widely used in
various dental disciplines: postsurgical
care, bone remodelling, neural
restoration, orofacial pain relief and,
more recently, the treatment of peri-
odontal disease (12–14).
According to the Arndt–Schultz
law, the desirable biological reactions
must be triggered within a therapeutic
window (16). Doses below that range
are not suﬃcient to make a diﬀerence,
and doses over that range may have
inhibitory eﬀects. Lasers with wave-
lengths in the red and near-infrared
range exhibit less absorption by water
and tissue chromophores (haemoglo-
bin and melanin), thus penetrate dee-
per into tissue (5–10 mm) (13,16,17).
These properties make LLLT a
promising treatment strategy for soft
tissue wounds (11). It is believed that
LLLT functions via the mitochondrial
respiratory chain, resulting in the
increased production of adenosine
triphosphate and subsequently facili-
tating the proliferation of ﬁbroblasts,
release of growth factors and synthe-
sis of collagen (12,13,18,19). Mean-
while, in vitro and animal studies have
shown that LLLT suppresses inﬂam-
mation in periodontal tissue by modu-
lation of the local immune response
and by reducing the production and
release of certain proinﬂammatory
cytokines, such as tumour necrosis
factor alpha (TNF-a), interleukin-1b
(IL-1b) and prostaglandin E2 (20–23).
In addition, LLLT has been found to
improve the local microcirculation by
angiogenesis and vasodilation, thus
alleviating tissue oedema and inﬂam-
mation (24).
However, there are diﬀerences in
the results of the clinical trials that
have investigated the additional bene-
ﬁts of LLLT in non-surgical peri-
odontal treatment (25–32). Qadri
et al. (31) found that adjunctive treat-
ment with LLLT attenuated peri-
odontal inﬂammation over the short
term as assessed by the gingival index
(GI), plaque index (PI), probing
pocket depth (PPD) and matrix met-
alloproteinase-8 level in the gingival
crevicular ﬂuid. However, Lai et al.
(29) reported no signiﬁcant improve-
ment in any of their clinical parame-
ters, namely, PPD, clinical attachment
level or bleeding on probing (BOP),
between LLLT-mediated SRP and
SRP monotherapy. Because no previ-
ous systematic review has exclusively
addressed the eﬀectiveness of LLLT
as an adjunct to non-surgical period-
ontal treatment, it is essential to con-
duct an evidence-based study by
comprehensive assessment of the
accumulated data.
The objective of this systematic
review was to evaluate on the basis of
the results of randomized controlled
trials (RCTs) whether LLLT, in com-
bination with conventional mechani-
cal debridement, provides any addi
tional beneﬁts over SRP alone as
assessed by the clinical parameters
(PPD as the primary outcome) and
biochemical markers of periodontal
inﬂammation (secondary outcomes).
Material and methods
This systematic review was carried
out in accordance with the
Cochrane Handbook for Systematic
Review of Interventions and the Pre-
ferred Reporting Items for Systematic
Reviews and Meta-Analysis (PRI
SMA) (33,34).
Search strategy
An extensive literature search was
performed before August 2015 in the
Cochrane Library (Issue 8, 2015),
PubMed (1997) and EMBASE (1947).
Any record relevant to RCTs of the
adjunctive eﬀects of LLLT in non-
surgical periodontal treatment was
included for further screening with no
restrictions regarding the publication
year or language. The reference lists
of all selected full-text publications
were scanned at the same time. No
additional manual search of journals
was performed. The search terms
included ‘periodontitis’, ‘chronic peri-
odontitis’, ‘periodontal disease’, ‘peri-
odontal inﬂammation’, ‘gingival
inﬂammation’, ‘periodontal treat-
ment’, ‘dental scaling’, ‘scaling and
root planing’ and ‘non-surgical
periodontal treatment’ for the diseases
and circumstances under investiga-
tion; ‘laser irradiation’, ‘laser ther-
apy’, ‘phototherapy’, ‘diode laser’,
‘biostimulation’, ‘low-level laser’,
‘low-intensity laser’, ‘low-power
laser’, ‘low-energy laser’, ‘therapeutic
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laser’ and ‘soft laser’ for synonyms of
LLLT, combined with outcomes of
interest, including ‘plaque index’, ‘gin-
gival index’, ‘probing pocket depth’,
‘clinical attachment level’, ‘bleeding
on probing’, ‘gingival crevicular ﬂuid’
and ‘biochemical markers’.
Study selection
In the ﬁrst stage, the titles and abstracts
of all retrieved reports were screened
for potentially eligible studies. The full-
text articles of the previously identiﬁed
studies were then examined in detail
according to predeﬁned eligibility crite-
ria for inclusion in the qualitative
review. Finally, the references covered
by the selected studies were searched
manually to avoid the omission of any
information related to the topic. Two
reviewers performed the screening pro-
cess independently. Whenever there
was a disagreement between the two
reviewers regarding study selection, dis-
cussions were carried out until a con-
sensus was reached. The inter-reviewer
reliability was assessed by Cohen’s
kappa test, assuming 0.6 as an accept-
able threshold value.
Inclusion criteria
1 Studies included were RCTs that
examined the adjunctive eﬀects of
LLLT in non-surgical periodontal
treatment.
2 Participants were patients with the
diagnosis chronic periodontitis.
There were no restrictions in the
age, gender, ethnicity or socio-
economic status of the participants.
3 The participants were randomly
allocated to the intervention group
or to the control/placebo group.
Each participant underwent con-
ventional SRP (with an ultrasonic
scaler and/or hand instrumentation)
as their initial periodontal treat-
ment. The intervention group
underwent LLLT to the periodontal
tissue of the target teeth after SRP.
A sham laser was applied in the
placebo group, and no laser was
used in the control group.
4 The outcome variables included
clinical indices of periodontal
inﬂammation (i.e., PPD, clinical
attachment level, PI, GI, etc.) and
levels of biochemical or immuno-
logical markers (i.e., TNF-a, IL-1b
and prostaglandin E2) in the gingi-
val crevicular ﬂuid or the periodon-
tal tissue.
Exclusion criteria
1 Potential participants who had any
systematic disease or who were
under medication that was known
to aﬀect the inﬂammation progress
and wound healing of periodontal
tissue were excluded, as were any
who had undergone periodontal
treatment within the past 6 mo.
2 Any studies in which high-power
thermal lasers (output power of
1 W or greater) were applied for
calculus ablation, pocket debride-
ment or bacteria reduction were
excluded.
3 Any studies including photody-
namic therapy involving a low-level
laser in conjunction with a photo-
sensitizer were excluded.
Assessment of risk of bias
The risk of bias in the included studies
was evaluated with reference to the
Cochrane Tool for risk of bias assess-
ment (33). This tool consists of seven
evaluation domains, including ‘ran-
dom sequence generation’, ‘allocation
concealment’, ‘blinding of partici-
pants’, ‘blinding of key personnel’, ‘in-
complete outcome data’, ‘selective
reporting’ and ‘other bias’. The com-
prehensive methodological quality of
each study was judged as low risk if all
seven domains were rated as ‘having a
low risk of bias’, as moderate risk if at
least one domain was rated as ‘having
an unclear risk of bias’ and as high risk
if one or more domains was assessed as
‘having a high risk of bias’.
Data extraction
The following data were extracted
from the included studies: publication
information, country, study design,
sample size, subject characteristics
(such as demographic characteristics,
inclusion criteria for chronic peri-
odontitis and smoking habits), ran-
domization method, allocation concea
lment, blinding measures, intervention
and placebo or control approach,
laser parameters and regimen, out-
come measurements, follow-up dura-
tion, patients lost to follow-up and
the occurrence of any adverse events.
Statistical analysis
The meta-analysis was conducted
using REVMAN 5.3 (33). The weight of
each individual study included in the
meta-analysis for every eﬀect estimate
was determined by its reported stan-
dard deviation and sample size (33).
The eﬀect size was estimated and
reported as the mean diﬀerence (MD)
or standardized mean diﬀerence
(SMD) with the 95% conﬁdence inter-
val (CI) for clinical indices and bio-
chemical markers. Because each
analysis had a small number of stud-
ies, the between-studies variance was
poorly estimated. Thus, a ‘ﬁxed-eﬀect
model’ was adopted for all analyses
(34). Heterogeneity was assessed with
a chi-squared test and the I2 statistic
at an alpha level of 0.10. Moderate to
substantial heterogeneity was consid-
ered to exist if the I2 statistic was
greater than 50%. The statistical sig-
niﬁcance level for the hypothesis test
was set at an a level of 0.05 for two-
tailed z tests.
Results
Search and selection results
The process of study selection is
shown in Fig. 1. At the beginning,
672 records were identiﬁed from the
electronic and manual search. After
the removal of duplicates, 354 publi-
cations remained for independent
screening, of which 69 were deemed
potentially eligible on the basis of
their title and abstract (inter-reviewer
agreement, j = 0.94). An additional
61 studies were excluded after scan-
ning the full text (inter-reviewer agree-
ment, j = 0.93). Thus, the entire
procedure resulted in the inclusion of
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eight publications (seven RCTs)
involving 180 participants from seven
countries in the qualitative review
(25–32).
Characteristics of included studies
The study characteristics and laser
parameters are displayed in Tables 1
and 2, respectively. Three of the seven
RCTs included in this study adopted
a parallel-arm design (25–28), and the
rest used a split-mouth design (29–
32). There was great variation in the
number of participants enrolled in
each study (10–60). Despite a wide
age range (22–70 years old), all of the
studies but one (32) recruited adult
patients. All of the participants were
in good general health at the begin-
ning of the study. Although all partic-
ipants were diagnosed with chronic
periodontitis, diﬀerent criteria were
used at recruitment. Six of the studies
included patients with moderate to
advanced chronic periodontitis (25–
31), whereas one study recruited
patients with mild chronic periodonti-
tis (32). Most of the studies applied
PPD as an inclusion criterion, with
thresholds of 4–6 mm (28,30),
≤ 7 mm (31), 4–10 mm (27) and
≥ 5 mm (29). Some studies also took
into consideration tooth mobility
(27,31), site location (29) and angular
bone defect (29) during sample selec-
tion and matching. Smokers were
excluded by all but two studies
(27,31); one (27) included subjects
who smoked more than 10 cigarettes
per day and the other (31) gave no
deﬁnition for smoking. Only one
study (27) assessed the inﬂuence of
smoking status on the eﬀects of
LLLT on the patients’ clinical
parameters. Despite its less favour-
able eﬀect on the change in the sul-
cus bleeding index, it was found
that smoking status did not inﬂu-
ence the eﬀects of LLLT in the
reduction of the PPD or clinical
attachment level at a signiﬁcant
level. Meanwhile, adjunctive LLLT
in smokers showed a positive inter-
mediate-term eﬀect in the reduction
of the sulcus bleeding index, the
PPD and the clinical attachment
level after SRP.
Mechanical debridement, including
supragingival and/or subgingival SRP
combined with instruction on oral
hygiene was performed for all partici-
pants as their initial periodontal treat-
ment in a single (27,30) or multiple
sessions (25,26,28,29). A diode laser
with a wavelength ranging from 630
to 830 nm was used in most studies.
Nevertheless, the output power and
exposure time of LLLT diverged
greatly among studies, leading to an
energy dosage ranging from 0.12 to
12 J per tooth. Irradiation was
applied externally in slight contact
with the buccal and lingual gingival
surface in a static or scanning man-
ner, whereas in one study (28) the
irradiation penetrated into the pocket
via a diﬀusing tip. Although all of the
studies included multiple sessions of
irradiation, a large variation in regi-
mens was observed. Irradiation fre-
quencies varied from 4 to 10 sessions
within 3 mo after SRP, which yielded
an accumulative dosage of 1–30 J per
site (1–60 J per tooth). Interestingly,
one study compared the eﬀects of a
single session with multiple sessions
and obtained an outcome favouring
the latter in terms of the reduction in
inﬂammatory mediators (28). A
pseudo laser was used in three studies
to ensure the blinding of the partici-
pants (30–32).
Each of the RCTs examined clinical
parameters, and the levels of bio-
chemical markers in the gingival
crevicular ﬂuid were also assessed in
four studies (27,28,30,31). One study
assessed the level of TNF-a in gingi-
val biopsies (25,26). The alveolar bone
density was measured by radiography
in two studies (29,30). Microbial anal-
ysis of the subgingival plaque was
performed in one study (31); no sig-
niﬁcant diﬀerence was seen in the per-
centage of positive samples between
the laser and placebo groups. In addi-
tion, one study compared the pain
levels immediately after treatment and
found no signiﬁcant diﬀerence
between the intervention and placebo
groups (32). Notably, only three stud-
ies included more than 6 mo of fol-
low-up (27,29,30), and the others
merely recorded short-term outcomes
(25,26,28,31,32). No adverse events
were reported during follow-up in any
of the included studies.
Assessment of methodological
quality
As shown in Fig. 2, only one study
(31) was assessed as having a moder-
ate risk of bias with six studies (25–
30,32) as having a high risk of bias.
When analysed according to diﬀerent
domains, the methodological weak-
ness of the pooled evidence was
mainly attributed to ‘allocation con-
cealment’ and ‘blinding of key person-
nel’ (Fig. 3). Although all of the
studies were presented as RCTs, only
three described the manner in which
Fig. 1. PRISMA ﬂow diagram of the study inclusion process.
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the random sequence was generated
(27,28,30). Four of the included RCTs
failed to implement strict allocation
concealment to prevent foreknowledge
of the random sequence (27–30), and
the rest did not mention this issue
explicitly (25,26,31,32). Because clini-
cal indices and biochemical markers
were the objective outcome measures,
the eﬀect of a lack of true blinding of
participants on the study results was
considered insigniﬁcant. However, the
reliability of the results may be at risk
if key investigators who recruited
patients, performed SRP or assessed
the outcome data were aware of the
grouping information. It was found
that eﬀective masking of key person-
nel was neglected in two studies
(25,26,30) and was not described
clearly in another one (28). Some
patients were lost to follow-up in two
studies (29,32) without appropriate
explanation or management. There
was insuﬃcient information to assess
whether the outcomes were reported
selectively in any of the included stud-
ies.
Effect of intervention
Short-term eﬀects— Four studies
(27,28,30,31) provided adequate data
on clinical parameters including the
PI, PPD and clinical attachment level,
along with the amount of IL-1b in
the gingival crevicular ﬂuid, which
was obtained 1 or 2 mo after treat-
ment. A meta-analysis was thus con-
ducted to assess the short-term
adjunctive eﬀects of LLLT (Table 3).
The PPD was signiﬁcantly lower in
the LLLT-mediated group than in the
SRP group at 1 mo (MD, 0.40;
95% CI, 0.64 to 0.17; p = 0.0009)
and at 2 mo (MD, 0.28; 95% CI,
0.54 to 0.03; p = 0.03). Mean-
while, in comparison with the control
group, a marginal improvement in the
PI was observed in the LLLT-adjunc-
tive group (MD, 0.22; 95% CI,
0.44 to 0; p = 0.06). With regard to
inﬂammatory cytokines, LLLT pro-
duced a signiﬁcant additional eﬀect in
the reduction of IL-1b levels in the
gingival crevicular ﬂuid at 1 mo
(SMD, 0.77; 95% CI, 1.35 to
0.18; p = 0.01). However, no signiﬁ-Ta
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cant diﬀerence was detected in favour
of the adjunctive use of LLLT with
regard to the clinical attachment level
(MD, 0.21; 95% CI, 1.08 to 0.67;
p = 0.65).
Intermediate-term eﬀects— As shown
in Table 4, intermediate-term evalua-
tions were made in three studies
(27,29,30) at 3 and 6 mo. Compared
with SRP alone, the use of LLLT as
an adjunct provided no signiﬁcant
improvement in the PI (MD, 0.03;
95% CI, 0.32 to 0.26; p = 0.84 for
3 mo; MD, 0.08; 95% CI, 0.27 to
0.10; p = 0.39 for 6 mo), the PPD
(MD, 0.28; 95% CI, 0.56 to 0.01;
p = 0.06 for 3 mo; MD, 0.01; 95%
CI, 0.15 to 0.12; p = 0.88 for 6 mo)
or the clinical attachment level (MD,
0.07; 95% CI, 0.58 to 0.71; p = 0.84
for 3 mo; MD, 0.04; 95% CI, 0.62
to 0.69; p = 0.91 for 6 mo). No signif-
icant diﬀerence was seen in the alveo-
lar bone density between the group
with adjunctive LLLT and the SRP
group (SMD, 0.18; 95% CI, 0.33 to
0.69; p = 0.48 for 6 mo).
Discussion
LLLT has long been recommended to
facilitate wound healing because it is
a non-invasive therapy with biostimu-
latory and anti-inﬂammatory proper-
ties (11–14). However, previous
systematic reviews have either focused
on the application of thermal lasers in
periodontal treatment or assessed the
clinical eﬀects of high-power and low-
power lasers as a whole (9,10,35,36).
Few evidence-based studies can be
found to clarify whether LLLT adds
beneﬁt to the traditional non-surgical
periodontal treatment. Therefore, this
systematic review was conducted to
elucidate this research question. The
current body of evidence indicates
that LLLT in conjunction with SRP
shows some short-term superiority as
assessed by the PPD, but it appears
equivalent to SRP monotherapy in
the intermediate term. However, the
results of this systematic review
should be interpreted with caution
because of the considerable method-
ological shortcomings and substantial
heterogeneity among the includedT
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studies. Several factors require much
attention before research can be con-
ducted and decisions made.
Sample selection and matching of
intervention arms
Great variation was noted in the
inclusion criteria, which covered mild,
moderate and advanced categories of
chronic periodontitis (Table 1). More-
over, some studies made judgments
on the basis of comparable pocket
depth, and some supplemented this
criterion with tooth mobility and
bone level. Nevertheless, one study
(25,26) failed to describe clearly their
diagnostic and inclusion criteria. The
pocket depth has been shown as a
critical indicator of the eﬀectiveness
of non-surgical periodontal treatment
(37). Greater reductions in the PPD
and gains in the clinical attachment
level are expected in patients with
deeper pockets (29). However, only
one study (27) analysed the eﬀects of
LLLT according to subgroups of
patients with moderate (4–6 mm) and
deep (6–10 mm) pockets. LLLT was
found to be eﬀective in the reduction
of PPD in both subgroups in compar-
ison with their counterparts in the
control group. Meanwhile, it
appeared equally beneﬁcial for the
reduction of the clinical attachment
level between subgroups at 6 mo (27).
However, this conclusion should be
applied carefully because no further
clues could be obtained to support
the balanced distribution of the two
levels of pocket depth between the
experiment and control groups men-
tioned above. Smoking is considered
another principal factor that has a
negative eﬀect on the prognosis of
Fig. 2. Risk of bias summary: review authors’ judgments about each risk of bias item for
each included study.
Fig. 3. Risk of bias graph: review authors’ judgments about each risk of bias item presented as percentages across all included studies.
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periodontal disease (38). All of the
studies addressed this issue at recruit-
ment. However, only one study gave
an explicit deﬁnition of the smoking
status and matched the smokers
between the laser and control groups
(27). The smokers and non-smokers
were analysed and compared as sub-
groups in this study. LLLT was found
to produce additional favourable
eﬀects on the clinical parameters
among the smoking subjects. This
eﬀect was attributed to the positive
role of LLLT in the microcirculation,
in the synthesis of collagen and in
cytokine modulation, which are nega-
tively aﬀected by smoking (27). At the
same time, LLLT was shown to pro-
duce comparable eﬀects in the reduc-
tion of the PPD and the clinical
attachment level between smokers and
non-smokers (27). Notably, none of
the included studies conducted a cal-
culation of sample size beforehand to
estimate the minimum number of sub-
jects needed to detect a signiﬁcant dif-
ference between the groups. These
defects in sample selection and group
matching may put the reliability of
research outcomes at risk.
Intervention and control measures
Although SRP was implemented in all
of the participants as the initial ther-
apy, there was no clear description of
the post-debridement maintenance.
Only one study conducted strict long-
term oral hygiene instruction to
ensure that only participants with
good oral hygiene status and compli-
ance were enrolled (30). It is known
that good oral hygiene control serves
as a prerequisite for successful treat-
ment outcomes (3). Thus, explicit pre-
deﬁned criteria should be set to make
the results comparable between
groups and studies.
It is believed that the eﬃcacy of
laser therapy depends on a combina-
tion of parameters, including the
wavelength, spot size, output power,
energy dosage, exposure time and
irradiation frequency (39). The wave-
length plays a key role in laser–tissue
interaction by modulation of the scat-
tering and absorption characteristics
(17,39). Meanwhile, a biphasic dose
response is considered to inﬂuence the
clinical eﬀectiveness of LLLT, which
indicates the presence of a therapeutic
window for optimal tissue reaction
(16). Despite the eﬀorts of accumulat-
ing in vivo and in vitro studies, the
exact dosage range remains controver-
sial (19,25–32,40,41). Some research-
ers recommended an energy dose of
1–10 J/cm2 for periodontal tissue
(40,42,43). Substantial heterogeneity
was seen in the laser parameters and
regimens among the included studies,
with wavelengths ranging from 630 to
830 nm, output powers ranging from
0.2 to 250 mW, energy densities rang-
ing from 1.7 to 24 J/cm2, and applica-
tion frequencies ranging from 4 to 10
sessions within 3 mo after SRP
(Table 2). However, given the insuﬃ-
Table 4. Meta-analysis of LLLT’s intermediate-term additional eﬀects, comparison: SRP+LLLT versus SRP, outcome: clinical parameters
(PI, PPD, CAL) and alveolar bone density at 3 and 6 mo
Evaluation
interval Outcome Studies
Number of
participants Model
Test for total eﬀect Test for heterogeneity
MD/SMD 95% CI P value I2 value (%) P value
3 mo PI (27,30) 68 Fixed 0.03 0.32 to 0.26 0.84 0 0.69
PPD (27,29,30) 96 Fixed 0.28 0.56 to 0.01 0.06 0 0.83
CAL (27,29) 64 Fixed 0.07 0.58 to 0.71 0.84 0 0.53
6 mo PI (27,30) 68 Fixed 0.08 0.27 to 0.10 0.39 0 0.69
PPD (27,29,30) 96 Fixed 0.01 0.15 to 0.12 0.88 0 0.74
CAL (27,29) 64 Fixed 0.04 0.62 to 0.69 0.91 0 0.88
Alveolar
bone density
(29,30) 60 Fixed 0.18a 0.33 to 0.69 0.48 0 0.40
MD, mean diﬀerence; SMD, standardized mean diﬀerence; CI, conﬁdence interval; PI, plaque index; PPD, probing pocket depth; CAL,
clinical attachment level.
aIntervention eﬀect reported as SMD.
Table 3. Meta-analysis of LLLT’s short-term additional eﬀects, comparison: SRP+LLLT versus SRP, outcome: clinical parameters (PI,
PPD, CAL) and biochemical markers (IL-1b) at 1 and 2 mo
Evaluation
interval Outcome Studies
Number of
participants Model
Test for total eﬀect Test for heterogeneity
MD/SMD 95% CI p Value I2 value (%) p Value
1 mo PI (27,30) 68 Fixed 0.22 0.44 to 0.00 0.06 0 0.32
PPD (27,28,30) 86 Fixed 0.40 0.64 to 0.17 0.0009* 0 0.65
CAL (27,28) 54 Fixed 0.21 1.08 to 0.67 0.65 0 0.89
IL-1b (28,30) 50 Fixed 0.77a 1.35 to 0.18 0.01* 0 0.43
2 mo PPD (28,31) 52 Fixed 0.28 0.54 to 0.03 0.03* 86 0.009
MD, mean diﬀerence; SMD, standardized mean diﬀerence; CI, conﬁdence interval; PI, plaque index; PPD, probing pocket depth; CAL,
clinical attachment level; IL-1b, Interleukin-1b.
aIntervention eﬀect reported as SMD.
*p < 0.05, signiﬁcant diﬀerence between SRP + LLLT and SRP.
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cient number of studies included, no
sensitivity analysis or meta-regression
could be conducted to explore the
eﬀects of the laser parameters on
their clinical eﬀects. Interestingly, one
study (28) compared the eﬀects of a
single session of irradiation with mul-
tiple LLLTs and reached a conclu-
sion in favour of the multiple
application method in the reduction
of proinﬂammatory mediators, which
is in agreement with some current
perspectives (12,16,44). It was indi-
cated that regular irradiation during
the periodontal treatment course may
produce more favourable eﬀects.
Remarkably, important parameters
such as the spot size, energy dosage
and application method were not
detailed in some studies (27,28),
which undermined the quality of the
collective evidence.
Study design and outcome
assessment
It is believed that the host response
plays a key role in the progression of
periodontal disease (45). By this
token, a split-mouth design serves as
a good choice by which to eliminate
intersubject variance, which is diﬃcult
to control even with perfect matching.
In addition, a smaller sample size is
required under this circumstance to
achieve equal test power (46). In con-
sideration of these merits, over half of
the included studies adopted a con-
tralateral control model (29–32). Nev-
ertheless, it must be borne in mind
that a carryover eﬀect would diminish
the true eﬀects of intervention that
are under investigation (47). Thus, the
rationale of the split-mouth design
should be based on a lack of veriﬁed
systematic eﬀects of LLLT. Owing to
the small number of studies included,
no subgroup analysis could be per-
formed to examine the diﬀerences in
the eﬀects of intervention between the
studies with split-mouth and parallel-
arm designs.
A remarkable shortcoming was
seen in the methods of the included
studies as assessed by the Cochrane
Tool for risk of bias evaluation
(Figs 2 and 3). Major drawbacks were
observed to lie in ‘allocation conceal-
ment’ and ‘blinding of key personnel’.
More than half of the studies included
were conducted without eﬀective mea-
sures to protect the allocation
sequence (27–30), and two failed to
mask the outcome assessors or clinical
operators (25,26,30). Furthermore, the
methods of random sequence genera-
tion were not described explicitly in
four of the included studies, which
could have potentially biased the
results (25,26,29,31,32).
Instead of calculus ablation and
bacteria reduction, the eﬀects of
LLLT are mainly shown as photo-
chemical and photobiological, which
may play a larger role in the mainte-
nance and healing processes of peri-
odontitis (12). Thus, as a key
indicator for the outcome of non-sur-
gical periodontal treatment, the PPD
was chosen as the primary outcome
and other clinical periodontal indices
(clinical attachment level, PI and GI)
along with gingival crevicular ﬂuid
levels of biochemical markers (IL-1b)
as the secondary outcomes in this
review. In terms of clinical indices,
only a short-term trend was observed
in favour of the LLLT-adjunctive
group in PPD reduction (Table 3).
LLLT also showed some short-term
additional beneﬁts in the reduction of
plaque and improvement of the gingi-
val condition (25–27,31). However,
with further examination of the inter-
mediate-term eﬀects, no signiﬁcant
diﬀerences were revealed in the
improvement of the clinical parame-
ters or the alveolar bone density
between LLLT-mediated SRP and
SRP monotherapy (Table 4). Thus, it
was speculated that, after traditional
SRP, the adjunctive eﬀects of LLLT
on the modulation of acute gingival
inﬂammation and the alleviation of
tissue oedema account for the extra
decrease in pocket depth in the short
term (12). This speculation was
strengthened by the demonstrated
eﬀects of LLLT on the reduction of
IL-1b levels in the gingival crevicular
ﬂuid (Table 3). Multiple proinﬂamma-
tory cytokines in the gingival crevicu-
lar ﬂuid (i.e., IL-1, IL-6 and TNF-a)
have been found to correlate closely
with the status of periodontitis; this
ﬁnding greatly beneﬁts the diagnosis,
treatment and prognosis of periodon-
tal disease (48). Although they have
already been documented by a num-
ber of in vitro studies (20–23), the
eﬀects of LLLT on the levels of
proinﬂammatory cytokines in the gin-
gival crevicular ﬂuid appeared contro-
versial among the clinical trials. For
the ﬁrst time, biochemical markers
were assessed quantitatively in rele-
vant systematic reviews. Considering
the great variation in the selected
cytokines and evaluation time-points
among the limited number of studies,
only the data regarding the short-term
levels of IL-1b in the gingival crevicu-
lar ﬂuid could be synthesized and
analysed. Thus, the exact eﬀects of
LLLT on the inﬂammatory mediators
require further veriﬁcation. More
importantly, because it takes months
or even years for the periodontal tis-
sue to restore and maintain health
after mechanical therapy, most studies
adopted a follow-up duration of less
than 6 mo, leaving unexplored the
long-term eﬀects of LLLT (49).
Implications for future research
Given the weaknesses of the current
evidence identiﬁed in this review, the
following suggestions are proposed for
future clinical studies. Initially, the
inclusion criteria of periodontal
patients should be carefully designed
before the experiment and clearly
reported in the manuscript. Factors
that may inﬂuence disease progression,
such as the pocket depth and smoking
status, should be taken into account
when recruiting and matching partici-
pants for both the split-mouth and par-
allel-arm designs. Sample-size
estimation is advisable for RCTs.
Moreover, it is important that both
intervention and control measures fol-
low predeﬁned guidelines to reduce
bias. It is suggested that laser parame-
ters be chosen based on existing evi-
dence and reported in a standardized
and detailed manner. In addition, the
risks and beneﬁts should be balanced
and discussed regardless of which study
design is chosen. In addition, eﬀective
measures should be taken to reduce the
risk of bias in the study methods, with
special attention paid to allocation
18 Ren et al.
concealment and blinding. Last but not
least, longer durations of follow-up,
adequate irradiation regimens and fur-
ther exploration of biochemical mark-
ers are anticipated.
Conclusions
Although LLLT is widely recom-
mended for its biostimulatory and
anti-inﬂammatory roles, it only
showed additional short-term merits
in reducing the pocket depth after
conventional SRP. However, its inter-
mediate-term eﬀects were found to be
non-signiﬁcant. Its long-term adjunc-
tive beneﬁts remain unclear because
of the substantial methodological
weaknesses and the insuﬃcient num-
ber of existing studies. Future RCTs
with better study designs, adequate
sample power and longer durations of
follow-up are required to assess the
eﬀectiveness of LLLT as an adjunc-
tive treatment strategy in patients
with periodontal disease.
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time-point: 6 mo.
Figure S5. Comparison: SRP + LL
LT versus SRP; Outcome: PPD; Evalua-
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